Full Text Full Text (PDF) CME: Take the course for this article: AJP CME Course for May 2007: Differences in Brain Glucose Metabolism Betwee... Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kennedy, S. H. Articles by Mayberg, H. S. Search for Related Content PubMed Citation Articles by Kennedy, S. H. Articles by Mayberg, H. S. Neuroendocrinology Behavior Therapy Cognitive Therapy Related Article

Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial

OBJECTIVE: Neuroimaging investigations reveal changes in glucose metabolism (fluorine-18-fluorodeoxyglucose positron emission tomography [PET]) associated with response to disparate antidepressant treatment modalities, including cognitive behavior therapy (CBT), antidepressant pharmacotherapies, and deep brain stimulation. Using a nonrandomized design, the authors previously compared changes following CBT or paroxetine in depressed patients. In this study, the authors report changes in fluorine-18-fluorodeoxyglucose PET in responders to CBT or venlafaxine during a randomized controlled trial. MethodsSubjects meeting DSM-IV-TR criteria for a major depressive episode and a diagnosis of a major depressive disorder received a fluorine-18-fluorodeoxyglucose PET scan before randomization and after 16 weeks of antidepressant treatment with either CBT (N=12) or venlafaxine (N=12). Modality-specific and modality-independent regional brain metabolic changes associated with response status were analyzed. RESULTS: Response rates were comparable between the CBT (7/12) and venlafaxine (9/12) groups. Response to either treatment modality was associated with decreased glucose metabolism bilaterally in the orbitofrontal cortex and left medial prefrontal cortex, along with increased metabolism in the right occipital-temporal cortex. Changes in metabolism in the anterior and posterior parts of the subgenual cingulate cortex and the caudate differentiated CBT and venlafaxine responders. CONCLUSIONS: Responders to either treatment modality demonstrated reduced metabolism in several prefrontal regions. Consistent with earlier reports, response to CBT was associated with a reciprocal modulation of cortical-limbic connectivity, while venlafaxine engaged additional cortical and striatal regions previously unreported in neuroimaging investigations.

Related Article:

In This Issue
Am J Psychiatry 2007 164: A56. [Full Text] [PDF]

This article has been cited by other articles:

				S. C. Yudofsky Changing Tides in Neurosurgical Interventions for Treatment-Resistant Depression Am J Psychiatry, June 1, 2008; 165(6): 671 - 674. [Full Text] [PDF]

				H. Johansen-Berg, D. A. Gutman, T. E. J. Behrens, P. M. Matthews, M. F. S. Rushworth, E. Katz, A. M. Lozano, and H. S. Mayberg Anatomical Connectivity of the Subgenual Cingulate Region Targeted with Deep Brain Stimulation for Treatment-Resistant Depression Cereb Cortex, June 1, 2008; 18(6): 1374 - 1383. [Abstract] [Full Text] [PDF]

				M. L. Phillips, M. J. Travis, A. Fagiolini, and D. J. Kupfer Medication Effects in Neuroimaging Studies of Bipolar Disorder Am J Psychiatry, March 1, 2008; 165(3): 313 - 320. [Abstract] [Full Text] [PDF]

				Bibliography for Major Depressive Disorder and Suicide Focus, January 1, 2008; 6(1): 58 - 62. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us